---
title: "AstraZeneca's Baxfendy wins EU panel backing for hypertension treatment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305456995.md"
description: "AstraZeneca's hypertension drug Baxfendy (baxdrostat) received a positive regulatory recommendation from the EU panel. If approved, it will become the European Union's first aldosterone synthase inhibitor for adults with uncontrolled high blood pressure."
datetime: "2026-11-13T11:47:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305456995.md)
  - [en](https://longbridge.com/en/news/305456995.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305456995.md)
generator: "portal-rs"
---

# AstraZeneca's Baxfendy wins EU panel backing for hypertension treatment

-   AstraZeneca’s Baxfendy (baxdrostat) received a positive EU regulatory recommendation for adults with hypertension insufficiently controlled by at least two medications. \* If approved, Baxfendy would become the EU’s first aldosterone synthase inhibitor. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AstraZeneca plc published the original content used to generate this news brief via Cision (Ref. ID: 202611130646BITN\_\_**UKPR**SV\_20261112-BIT-8659-0) on November 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)

## Related News & Research

- [REG - AstraZeneca PLC - Baxfendy recommended for approval in the EU](https://longbridge.com/en/news/305628944.md)
- [AstraZeneca's sonesitatug vedotin gets FDA priority review for advanced gastric cancers](https://longbridge.com/en/news/306076537.md)
- [AZ beefs up myasthenia gravis pedigree with US, EU Klygefa nods](https://longbridge.com/en/news/305697522.md)
- [AstraZeneca secures FDA approval for Imfinzi combo in MIBC](https://longbridge.com/en/news/305649865.md)
- [AstraZeneca fends off lawsuit over alleged Soliris drug monopoly](https://longbridge.com/en/news/305701830.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**